ARCHIVES

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Two-Month Longer Survival Found With Gliadel Wafer

March 31, 2006

Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements

January 23, 1998

NCAB Committee Seeks Organ Systems Upgrade

February 7, 1986

House Bill Gives NCI $48 Mil. Less Than Clinton Requested

July 8, 1994

ONS Scientific Program Grows

June 20, 1980

Obituary: Martin Abeloff, 65, Cancer Center Director At Johns Hopkins.

September 21, 2007